Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease

[1] Roth GA(2020)GBD-NHLBI-JACC global burden of cardiovascular diseases writing group. global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study J Am Coll Cardiol 76 2982-3021

[2] Mensah GA(2019)World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions Lancet Glob Health 7 1332-1146

[3] Johnson CO(2009)Chronic coronary artery disease: diagnosis and management Mayo Clin Proc 84 1130-38

[4] Addolorato G(2008)Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis Circ Cardiovasc Genet 1 31-533

[5] Ammirati E(2021)The changing landscape of atherosclerosis Nature 592 524-610

[6] Baddour LM(2022)Novel biomarkers of atherosclerotic vascular disease-latest insights in the research field Int J Mol Sci 23 4998-D368

[7] Barengo NC(2018)Peripheral-blood gene expression profiling studies for coronary artery disease and its severity in Xinjiang population in China Lipids Health Dis 17 154-287

[8] Beaton AZ(2021)Gene expression analysis suggests immunological changes of peripheral blood monocytes in the progression of patients with coronary artery disease Front Genet 11 641117-22

[9] Benjamin EJ(2020)Genes associated with inflammation may serve as biomarkers for the diagnosis of coronary artery disease and ischaemic stroke Lipids Health Dis 19 37-874

[10] Benziger CP(2020)Six-gene signature associated with immune cells in the progression of atherosclerosis discovered by comprehensive bioinformatics analyses Cardiovasc Ther 2020 1230513-2638

[1] Roth GA(2020)GBD-NHLBI-JACC global burden of cardiovascular diseases writing group. global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study J Am Coll Cardiol 76 2982-3021

[2] Mensah GA(2019)World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions Lancet Glob Health 7 1332-1146

[3] Johnson CO(2009)Chronic coronary artery disease: diagnosis and management Mayo Clin Proc 84 1130-38

[4] Addolorato G(2008)Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis Circ Cardiovasc Genet 1 31-533

[5] Ammirati E(2021)The changing landscape of atherosclerosis Nature 592 524-610

[6] Baddour LM(2022)Novel biomarkers of atherosclerotic vascular disease-latest insights in the research field Int J Mol Sci 23 4998-D368

[7] Barengo NC(2018)Peripheral-blood gene expression profiling studies for coronary artery disease and its severity in Xinjiang population in China Lipids Health Dis 17 154-287

[8] Beaton AZ(2021)Gene expression analysis suggests immunological changes of peripheral blood monocytes in the progression of patients with coronary artery disease Front Genet 11 641117-22

[9] Benjamin EJ(2020)Genes associated with inflammation may serve as biomarkers for the diagnosis of coronary artery disease and ischaemic stroke Lipids Health Dis 19 37-874

[10] Benziger CP(2020)Six-gene signature associated with immune cells in the progression of atherosclerosis discovered by comprehensive bioinformatics analyses Cardiovasc Ther 2020 1230513-2638